The Pediatric Infectious Disease Journal · 2014 · 41 citations · 5 references
PharmacyInfectious DiseasesPharmacotherapyAntimicrobial PharmacotherapyPediatric Infectious DiseasesPediatric PharmacotherapyLatent Tuberculosis InfectionPediatric Antimicrobial TherapyPediatric TuberculosisPulmonary TuberculosisTuberculosis In ChildrenTuberculosis PharmacotherapyAdverse Treatment EffectsLatent Tuberculosis Infection TherapyLatent Tuberculosis Infection TreatmentMedication Adverse EffectsMultidrug-resistant Tuberculosis TreatmentPediatric Latent Tuberculosis InfectionPediatric Tuberculosis ManagementPediatric Tuberculosis Treatment
After exposure to a teacher with multidrug-resistant pulmonary tuberculosis, 31 children developed latent infection. Twenty-six were treated with levofloxacin and pyrazinamide. Twelve required a change in therapy secondary to adverse effects. The most common adverse effects included abdominal pain, arthralgias/myalgias and elevated transaminases. All children reported at least 1 adverse effect. Fifteen children completed treatment. All adverse effects were transient.
5